Altimmune, Inc. (ALT)
2.10
+0.05
(+2.44%)
USD |
NASDAQ |
Oct 27, 11:37
Altimmune Market Cap : 408.40M for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 398.67M |
| October 23, 2026 | 412.29M |
| October 22, 2026 | 422.01M |
| October 21, 2026 | 433.68M |
| October 20, 2026 | 447.29M |
| October 19, 2026 | 433.68M |
| October 16, 2026 | 427.84M |
| October 15, 2026 | 458.96M |
| October 14, 2026 | 449.24M |
| October 13, 2026 | 472.57M |
| October 12, 2026 | 497.85M |
| October 09, 2026 | 507.58M |
| October 08, 2026 | 505.63M |
| October 07, 2026 | 517.30M |
| October 06, 2026 | 519.25M |
| October 05, 2026 | 519.25M |
| October 02, 2026 | 531.89M |
| October 01, 2026 | 536.75M |
| September 30, 2026 | 556.20M |
| September 29, 2026 | 577.59M |
| September 28, 2026 | 575.64M |
| September 25, 2026 | 595.09M |
| September 24, 2026 | 591.20M |
| September 23, 2026 | 620.37M |
| September 22, 2026 | 663.16M |
| Date | Value |
|---|---|
| September 21, 2026 | 635.93M |
| September 18, 2026 | 632.04M |
| September 17, 2026 | 630.10M |
| September 16, 2026 | 630.10M |
| September 15, 2026 | 628.15M |
| September 14, 2026 | 641.76M |
| September 11, 2026 | 635.93M |
| September 10, 2026 | 639.82M |
| September 09, 2026 | 651.49M |
| September 08, 2026 | 653.43M |
| September 04, 2026 | 665.10M |
| September 03, 2026 | 628.15M |
| September 02, 2026 | 637.88M |
| September 01, 2026 | 600.93M |
| August 31, 2026 | 604.81M |
| August 28, 2026 | 604.81M |
| August 27, 2026 | 630.10M |
| August 26, 2026 | 612.59M |
| August 25, 2026 | 622.32M |
| August 24, 2026 | 604.81M |
| August 21, 2026 | 604.81M |
| August 20, 2026 | 573.70M |
| August 19, 2026 | 606.76M |
| August 18, 2026 | 577.59M |
| August 17, 2026 | 583.42M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Protalix Biotherapeutics, Inc. | 202.23M |
| Taysha Gene Therapies, Inc. | 1.342B |
| Humacyte, Inc. | 119.01M |
| Liquidia Corp. | 3.977B |
| Agenus, Inc. | 266.77M |
Market Cap Related Metrics
| PS Ratio | 8466.67 |
| Price to Book Value | 0.8612 |
| Price | 2.10 |
| Earnings Yield | -37.57% |